A first-in-human trial shows the feasibility and safety of delivering placenta-derived stem cells during prenatal ...

A first in-human, phase I trial examined feasibility as well as safety ...

Stem cell therapy on babies in the womb ‘can reverse brain issues linked to major birth defect’ - Spina bifida happens when a baby’s spine does not develop fully in the womb ...

The International Society for Stem Cell Research (ISSCR) proudly announces Kyle M. Loh, Stanford University School of Medicine, as the recipient of the 2026 ISSCR Early Career Impact Award, ...

Organotics, a brain organoid startup, uses AI and patient-derived brain models to fast-track personalized medicine for autism and reduce psychiatric drug failure.

Stem cell therapy performed while babies are still in the womb could help reverse brain abnormalities associated with a ...

Combining stem cell therapy with standard foetal surgery before birth is a safe and promising approach to treat a severe form ...